Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epithelial expression and function of trypsin-3 in irritable bowel syndrome
Claire Rolland-Fourcade, Alexandre Denadai‐Souza, Carla Cirillo, et al.
Gut (2017) Vol. 66, Iss. 10, pp. 1767-1778
Open Access | Times Cited: 107

Showing 1-25 of 107 citing articles:

Protease-activated receptors (PARs): mechanisms of action and potential therapeutic modulators in PAR-driven inflammatory diseases
Dorothea M. Heuberger, Reto A. Schuepbach
Thrombosis Journal (2019) Vol. 17, Iss. 1
Open Access | Times Cited: 295
Local immune response to food antigens drives meal-induced abdominal pain
Javier Aguilera‐Lizarraga, Morgane Florens, Maria Francesca Viola, et al.
Nature (2021) Vol. 590, Iss. 7844, pp. 151-156
Open Access | Times Cited: 219
Visceral Pain
Luke Grundy, Andelain Erickson, Stuart M. Brierley
Annual Review of Physiology (2018) Vol. 81, Iss. 1, pp. 261-284
Closed Access | Times Cited: 201
Understanding neuroimmune interactions in disorders of gut–brain interaction: from functional to immune-mediated disorders
Tim Vanuytsel, Přemysl Berčík, Guy E. Boeckxstaens
Gut (2023) Vol. 72, Iss. 4, pp. 787-798
Open Access | Times Cited: 66
Protease-activated receptor-2 in endosomes signals persistent pain of irritable bowel syndrome
Nestor N. Jiménez-Vargas, Luke A. Pattison, Peishen Zhao, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 31
Open Access | Times Cited: 160
Characterization of Human Colon Organoids From Inflammatory Bowel Disease Patients
Emilie d'Aldebert, Muriel Quaranta, Morgane Sébert, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 103
Duplex metal co-doped carbon quantum dots-based drug delivery system with intelligent adjustable size as adjuvant for synergistic cancer therapy
Chuyi Han, Xian‐Ming Zhang, Fan Wang, et al.
Carbon (2021) Vol. 183, pp. 789-808
Closed Access | Times Cited: 94
Serine proteases as luminal mediators of intestinal barrier dysfunction and symptom severity in IBS
Shoko Edogawa, Adam Edwinson, Stéphanie Peters, et al.
Gut (2019) Vol. 69, Iss. 1, pp. 62-73
Open Access | Times Cited: 78
Fecal Serine Protease Profiling in Inflammatory Bowel Diseases
Amin Jablaoui, Aïcha Kriaa, Héla Mkaouar, et al.
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 74
Immune activation in irritable bowel syndrome: what is the evidence?
Javier Aguilera‐Lizarraga, Hind Hussein, Guy E. Boeckxstaens
Nature reviews. Immunology (2022) Vol. 22, Iss. 11, pp. 674-686
Open Access | Times Cited: 61
Gut microbial β-glucuronidases regulate host luminal proteases and are depleted in irritable bowel syndrome
Adam Edwinson, Lu Yang, Stéphanie Peters, et al.
Nature Microbiology (2022) Vol. 7, Iss. 5, pp. 680-694
Open Access | Times Cited: 53
The emerging roles of bacterial proteases in intestinal diseases
Alberto Caminero, Mabel Guzmán, Josie Libertucci, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 32
Bisphenol A Analogues Induce Neuroendocrine Disruption via Gut–Brain Regulation in Zebrafish
Xiyan Mu, Zaiteng Liu, Xiaoyu Zhao, et al.
Environmental Science & Technology (2024) Vol. 58, Iss. 2, pp. 1022-1035
Closed Access | Times Cited: 10
Exploring the multicomponent synergy mechanism of Banxia Xiexin Decoction on irritable bowel syndrome by a systems pharmacology strategy
Bangjie Li, Junqian Rui, Xuejian Ding, et al.
Journal of Ethnopharmacology (2018) Vol. 233, pp. 158-168
Closed Access | Times Cited: 79
Functional Proteomic Profiling of Secreted Serine Proteases in Health and Inflammatory Bowel Disease
Alexandre Denadai‐Souza, Chrystelle Bonnart, Núria Solà Tapias, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 71
Update S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM) – Juni 2021 – AWMF-Registriernummer: 021/016
Peter Layer, Viola Andresen, H.‐D. Allescher, et al.
Zeitschrift für Gastroenterologie (2021) Vol. 59, Iss. 12, pp. 1323-1415
Open Access | Times Cited: 51
Multi-omics for biomarker approaches in the diagnostic evaluation and management of abdominal pain and irritable bowel syndrome: what lies ahead
Andrea Shin, Purna Kashyap
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 16
Molecular Mechanisms Underlying Loss of Vascular and Epithelial Integrity in Irritable Bowel Syndrome
Maria Raffaella Barbaro, Cesare Cremon, Giovanni Marasco, et al.
Gastroenterology (2024) Vol. 167, Iss. 6, pp. 1152-1166
Closed Access | Times Cited: 6
Active thrombin produced by the intestinal epithelium controls mucosal biofilms
Jean‐Paul Motta, Alexandre Denadai‐Souza, David Sagnat, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 52
Pharmacology of Intestinal Inflammation and Repair
Céline Deraison, Nathalie Vergnolle
The Annual Review of Pharmacology and Toxicology (2025) Vol. 65, Iss. 1, pp. 301-314
Closed Access
Protease signaling through protease activated receptor 1 mediate nerve activation by mucosal supernatants from irritable bowel syndrome but not from ulcerative colitis patients
Sabine Bühner, Hannes Hahne, Kerstin Hartwig, et al.
PLoS ONE (2018) Vol. 13, Iss. 3, pp. e0193943-e0193943
Open Access | Times Cited: 43
Existing and emerging therapies for managing constipation and diarrhea
Adil E. Bharucha, Mira M. Wouters, Jan Tack
Current Opinion in Pharmacology (2017) Vol. 37, pp. 158-166
Open Access | Times Cited: 41
Protease-Activated Receptors in the Intestine: Focus on Inflammation and Cancer
Morgane Sébert, Núria Solà-Tapias, Emmanuel Mas, et al.
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 41
Contribution of membrane receptor signalling to chronic visceral pain
Mahsa Sadeghi, Andelain Erickson, Joel Castro, et al.
The International Journal of Biochemistry & Cell Biology (2018) Vol. 98, pp. 10-23
Closed Access | Times Cited: 39
Newly developed serine protease inhibitors decrease visceral hypersensitivity in a post‐inflammatory rat model for irritable bowel syndrome
Hannah Ceuleers, Nikita Hanning, Jelena Heirbaut, et al.
British Journal of Pharmacology (2018) Vol. 175, Iss. 17, pp. 3516-3533
Open Access | Times Cited: 38
Page 1 - Next Page

Scroll to top